PRESS RELEASE published on 01/09/2025 at 09:00, 1 year 6 months ago Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency FDA Biotest AG Fibrinogen Biologics License Application Medical Treatment
BRIEF published on 11/15/2024 at 09:05, 1 year 7 months ago Minister and Mayor Advocate for Plasma Donations at Biotest's Center Biotest AG Public Awareness Plasma Donations Darmstadt Healthcare Employment
BRIEF published on 11/15/2024 at 09:05, 1 year 7 months ago Le ministre et le maire plaident en faveur des dons de plasma au centre Biotest Biotest AG Sensibilisation Du Public Darmstadt Dons De Plasma Emploi Dans Le Secteur De La Santé
PRESS RELEASE published on 11/15/2024 at 09:00, 1 year 7 months ago Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses Community Support Healthcare Biotest AG Plasma Donations Plasma Center
BRIEF published on 11/14/2024 at 10:19, 1 year 7 months ago Biotest Reports 4.5% Revenue Increase in First Nine Months of 2024 Financial Outlook Biotest Revenue Yimmugo® Growth Fibrinogen BT524 Grifols Agreement
BRIEF published on 11/14/2024 at 10:19, 1 year 7 months ago Biotest annonce une augmentation de son chiffre d'affaires de 4,5 % au cours des neuf premiers mois de 2024 Perspectives Financières Chiffre D'affaires De Biotest Croissance De Yimmugo® Fibrinogène BT524 Accord Grifols
PRESS RELEASE published on 11/14/2024 at 10:14, 1 year 7 months ago Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted Revenue Growth EBIT Biotest AG Product Sales Marketing Authorization
BRIEF published on 11/14/2024 at 09:01, 1 year 7 months ago Biotest AG Revises Revenue, Cash Flow, and ROCE Forecasts for 2024 Revenue Growth Financial Forecast Biotest AG ROCE EBIT Guidance
BRIEF published on 11/14/2024 at 09:01, 1 year 7 months ago Biotest AG révise ses prévisions de revenus, de flux de trésorerie et de ROCE pour 2024 Biotest AG ROCE Prévisions Financières Croissance Des Revenus Prévisions EBIT
PRESS RELEASE published on 11/14/2024 at 08:56, 1 year 7 months ago EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged Biotest AG corrects forecast for revenue, cash flow, and ROCE while maintaining EBIT guidance. Details on the adjustments made for the 2024 financial year disclosed Revenue Cash Flow Biotest AG ROCE Forecast Correction
Published on 07/13/2026 at 03:25, 6 hours 37 minutes ago SouthGobi Announces Inside Information JD Zhixing Fund L.P. Assigns Payment-In-Kind Interest Under Convertible Debenture
Published on 07/11/2026 at 02:50, 2 days 7 hours ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 2 days 8 hours ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 2 days 8 hours ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 2 days 10 hours ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/13/2026 at 09:55, 7 minutes ago One of the World's Largest Offshore Converter Stations Sets Sail for Guangdong
Published on 07/13/2026 at 09:36, 26 minutes ago Aareal Bank finances the acquisition of Marriott Zurich for Pictet Real Estate Capital
Published on 07/13/2026 at 09:20, 42 minutes ago DN Group AG: Investment in Algene starts series production of high-quality microalgae
Published on 07/13/2026 at 09:00, 1 hour 2 minutes ago Municipality Finance issues EUR 70 million zero coupon notes under its MTN programme
Published on 07/13/2026 at 09:00, 1 hour 2 minutes ago Municipality Finance issues EUR 50 million zero coupon notes under its MTN programme
Published on 07/13/2026 at 09:20, 41 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 mai 2026 bis
Published on 07/13/2026 at 07:30, 2 hours 32 minutes ago Déclaration hebdomadaire d'opérations effectuées du 6 au 10 juillet 2026
Published on 07/13/2026 at 07:30, 2 hours 32 minutes ago Disclosure of transactions in own shares from July 6 to July 10, 2026
Published on 07/10/2026 at 18:00, 2 days 16 hours ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 18:00, 2 days 16 hours ago Bilan semestriel du contrat de liquidité de la société CEGEDIM